Current role
Biotechnology · Healthcare
CEO, Board Member
2024-06-11–present
Ilya Rachman
Board Member
Immix Biopharma, Inc. (IMMX)Equibles does not estimate personal net worth.
Get an email with a short summary when Immix Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMMX alertsAbout Ilya Rachman
Ilya Rachman is recorded as Board Member at Immix Biopharma, Inc. (IMMX) since June 11, 2024 and CEO at Immix Biopharma, Inc. (IMMX). The newest filing on record that lists Ilya Rachman as CEO at Immix Biopharma, Inc. (IMMX) is dated April 6, 2026. Immix Biopharma, Inc. reported in an 8-K filed June 14, 2024 that Ilya Rachman was appointed director, effective June 11, 2024. The proxy statement of Immix Biopharma, Inc. reports total compensation of $1,352,854 for Ilya Rachman in fiscal 2025, including a base salary of $475,000. Disclosed compensation is on record for 6 fiscal years. Immix Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immix Biopharma, Inc. includes Gabriel Morris (CFO and Board Member), Carey Ng (Board Member), Helen C. Adams (Board Member) and 6 others.
“The individuals listed below were elected at the Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified:”
Affiliation history
-
Current
2024-06-11–present
-
Current
Start not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Immix Biopharma, Inc.
- Gabriel Morris CFO, Board Member
- Carey Ng Board Member
- Helen C. Adams Board Member
- Jane Buchan Board Member
- Jason Hsu Board Member
- Magda Marquet Board Member
- Nancy Chang Board Member
- Nancy Chang, Ph.D. Board Member
- Yekaterina Chudnovsky Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | $475,000 | $1,352,854 |
| 2024 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | $475,000 | $1,267,158 |
| 2023 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | $446,000 | $1,129,881 |
| 2022 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | $425,000 | $2,356,145 |
| 2021 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | $193,315 | $396,731 |
| 2020 | Immix Biopharma, Inc. (IMMX) | Chief Executive Officer | — | — |